Need of Clinical Pharmacist Intervention in irrational MI treatment; A case study

Asian Journal of Pharmaceutical and Health Sciences,2021,11,3,2523-2525.
Published:December 2021
Type:Original Article
Authors:
Author(s) affiliations:

Reshma Mariyam Johnson1, Ashitha M1, Kiron S.S2

1Pharm D, College of Pharmaceutical Sciences, Government Medical College Kannur, Kerala, INDIA.

2Professor, Department of Pharmacy Practice, , College of Pharmaceutical Sciences, Government Medical College Kannur, Kerala, INDIA.

Abstract:

A case on myocardial infarction (MI) is described. The subject complained of chest pain for two days aggravating 4 hours before admission to the emergency room. On evaluation the patient was diagnosed with anterolateral MI. Initial pharmacotherapy included aspirin, clopidogrel, atorvastatin, nicorandil, Inj heparin. Emergency cardiac catheterization and primary PTCA was performed. The drug therapy included aspirin, clopidogrel, rosuvastatin, carvedilol, pantoprazole, sorbitrate, injection heparin, tirofiban, ramipril, ivabradine, syrup KCl, torsemide, spironolactone, ranolazine, clonazepam. This case is a clear evidence of irrational prescription that includes polypharmacy, drug interaction and medication error. The prescription clearly depicts need of a clinical pharmacist intervention in overall therapy of the patient.

Need of clinical pharmacist intervention in irrational mi treatment a case study